Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.
Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF. Rocca B, et al. Among authors: halvorsen s. Eur Heart J. 2018 May 14;39(19):1672-1686f. doi: 10.1093/eurheartj/ehy066. Eur Heart J. 2018. PMID: 29509886 No abstract available.
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase.
Mistry N, Abdelnoor M, Seljeflot I, Hoffmann P, Bøhmer E, Bjørnerheim R, Kjeldsen SE, Halvorsen S. Mistry N, et al. Among authors: halvorsen s. J Card Fail. 2011 Jun;17(6):479-86. doi: 10.1016/j.cardfail.2011.02.006. Epub 2011 Apr 22. J Card Fail. 2011. PMID: 21624736 Clinical Trial.
IL-6 signalling in patients with acute ST-elevation myocardial infarction.
Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ. Ritschel VN, et al. Among authors: halvorsen s. Results Immunol. 2013 Dec 14;4:8-13. doi: 10.1016/j.rinim.2013.11.002. eCollection 2014. Results Immunol. 2013. PMID: 24707455 Free PMC article.
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D; Document Reviewers; Storey RF, Bueno H, Collet JP, Fauchier L, Halvorsen S, Lettino M, Morais J, Mueller C, Potpara TS, Rasmussen LH, Rubboli A, Tamargo J, Valgimigli M, Zamorano JL. Lip GY, et al. Among authors: halvorsen s. Eur Heart J. 2014 Dec 1;35(45):3155-79. doi: 10.1093/eurheartj/ehu298. Epub 2014 Aug 25. Eur Heart J. 2014. PMID: 25154388 Free article. No abstract available.
Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged.
Gershlick AH, Westerhout CM, Armstrong PW, Huber K, Halvorsen S, Steg PG, Ostojic M, Goldstein P, Carvalho AC, Van de Werf F, Wilcox RG. Gershlick AH, et al. Among authors: halvorsen s. Heart. 2015 May;101(9):692-8. doi: 10.1136/heartjnl-2014-306686. Epub 2015 Feb 17. Heart. 2015. PMID: 25691510 Clinical Trial.
525 results